In the company’s news yesterday,
WaferGen Biosystems, Inc. the signing of an exclusive distribution agreement with Euroclone S.p.A in Italy. Euroclone will distribute WaferGen’s SmartSlide™ Micro-Incubation System. WaferGen also signed a distributor agreement for SmartSlide with Takeda Rika Kogyo, Co. Ltd., of Japan. Both distributors serve cell biologists and stem cell researchers in the life science markets within their geographic areas.
WaferGen’s SmartSlide Micro-Incubation System is a unique family of integrated fluidics exchange micro-incubation products that work seamlessly with inverted microscopes. This breakthrough technology is enabling cell biology and stem cell researchers to conduct complex time-lapse imaging studies, to grow and work with stem cells and other difficult to cultivate cells. It allows researchers to pursue cutting-edge research topics that are not addressable with existing technology. As an example, the SmartSlide System will allow researchers to precisely control and vary oxygen, carbon dioxide, and nitrogen, in order to create conditions which are critical for growth and differentiation of stem cells.
Alnoor Shivji, WaferGen’s chairman and CEO said, “As evidenced by the signing of these additional distributor agreements in key foreign markets, we are continuing to build momentum with our SmartSlide Micro-Incubation System worldwide.”
About QualityStocks
QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their advertising efforts and now has over 500,000+ subscribers that receive The Daily Stock Newsletters.
To sign up for “The QualityStocks Daily Newsletter” please visit http://www.qualitystocks.net/
Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net
Forward-Looking Statement:
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.
